{{Drugbox
| verifiedrevid = 443362293
| IUPAC_name = 2-([4-(4-aminophenyl)sulfonylphenyl]amino)acetic acid
| image = Acediasulfone.png

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 80-03-5
| ATC_prefix = none
| ATC_suffix =
| ATC_supplemental =
| PubChem = 66451
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59823
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 30YP2YHH8W
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 48396

<!--Chemical data-->
| chemical_formula =
| C=14 | H=14 | N=2 | O=4 | S=1
| molecular_weight = 306.337 g/mol
| smiles = C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)NCC(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H14N2O4S/c15-10-1-5-12(6-2-10)21(19,20)13-7-3-11(4-8-13)16-9-14(17)18/h1-8,16H,9,15H2,(H,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FKKUMFTYSTZUJG-UHFFFAOYSA-N
}}

'''Acediasulfone''' ([[International Nonproprietary Name|INN]]) is an [[antimicrobial]] drug, which also has [[antimalarial]] activity. It is a long-acting [[prodrug]] of [[dapsone]], which is used for treating [[leprosy]].
== Synthesis ==
Dapsone is somewhat inconvient to administer to patients because of its rather low water solubility.
[[File:Acediasulfone synthesis.svg|thumb|center|700px|Acediasulfone synthesis:<ref>{{Cite journal|doi=10.1021/ja01182a074|pmid=18907772|title=Certain N-Alkyl, N-Carboxyalkyl and N-Hydroxyalkyl Derivatives of 4,4'-Diamino-diphenyl Sulfone|journal=Journal of the American Chemical Society|volume=70|issue=2|pages=680â€“4|year=1948|last1=Jackson|first1=Ernest L.}}</ref> {{Cite patent|CH|254803}} and {{Cite patent|CH|278482}} (1949, 1952, to [[Cilag]] Ltd.); Rawlins, {{US patent|2589211}} (1952 to [[Parke Davis]]).]]
In the search for more easily administered drugs, '''1''' was reacted with [[bromoacetic acid]] to give acediasulfone ('''3''') which can be adminsistered as a water soluble salt.
== References ==
<references />

{{antimicrobial-stub}}

[[Category:Sulfones]]
[[Category:Abandoned drugs]]